The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke

Trials ◽

10.1186/1745-6215-9-37 ◽

2008 ◽

Vol 9 (1) ◽

Author(s):

Peter Sandercock ◽

◽

Richard Lindley ◽

Joanna Wardlaw ◽

Martin Dennis ◽

...

Keyword(s):

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

The Third ◽

Download Full-text

Faculty Opinions recommendation of The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717297826.793153377 ◽

2012 ◽

Author(s):

Mark Wainwright

Keyword(s):

Randomised Controlled Trial ◽

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

Controlled Trial ◽

Intravenous Thrombolysis ◽

Recombinant Tissue Plasminogen Activator ◽

The Third ◽

Tissue Plasminogen ◽

Randomised Controlled ◽

Download Full-text

Faculty Opinions recommendation of The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717297826.792652833 ◽

2012 ◽

Author(s):

Harri Jenkins

Keyword(s):

Randomised Controlled Trial ◽

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

Controlled Trial ◽

Intravenous Thrombolysis ◽

Recombinant Tissue Plasminogen Activator ◽

The Third ◽

Tissue Plasminogen ◽

Randomised Controlled ◽

Download Full-text

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

10.1016/s0140-6736(12)60768-5 ◽

2012 ◽

Vol 379 (9834) ◽

pp. 2352-2363 ◽

Keyword(s):

Randomised Controlled Trial ◽

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

Controlled Trial ◽

Intravenous Thrombolysis ◽

Recombinant Tissue Plasminogen Activator ◽

The Third ◽

Tissue Plasminogen ◽

Randomised Controlled ◽

Download Full-text

Faculty Opinions recommendation of The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717297826.793453717 ◽

2012 ◽

Author(s):

Shyam Prabhakaran ◽

Laurel J Smit

Keyword(s):

Randomised Controlled Trial ◽

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

Controlled Trial ◽

Intravenous Thrombolysis ◽

Recombinant Tissue Plasminogen Activator ◽

The Third ◽

Tissue Plasminogen ◽

Randomised Controlled ◽

Download Full-text

Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(13)70130-3 ◽

2013 ◽

Vol 12 (8) ◽

pp. 768-776 ◽

Keyword(s):

Randomised Controlled Trial ◽

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

Controlled Trial ◽

Long Term Outcomes ◽

The Third ◽

Randomised Controlled ◽

Download Full-text

Faculty Opinions recommendation of The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717297826.793152901 ◽

2012 ◽

Author(s):

Todd Allen

Keyword(s):

Randomised Controlled Trial ◽

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

Controlled Trial ◽

Intravenous Thrombolysis ◽

Recombinant Tissue Plasminogen Activator ◽

The Third ◽

Tissue Plasminogen ◽

Randomised Controlled ◽

Download Full-text

Imaging perfusion deficits and thrombolysis safety and efficacy in acute ischaemic stroke: the Third International Stroke Trial

http://isrctn.org/> ◽

10.1186/isrctn25765518 ◽

2013 ◽

Author(s):

Peter A. G. Sandercock

Keyword(s):

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

Safety And Efficacy ◽

The Third ◽

Stroke Trial ◽

Perfusion Deficits

Download Full-text

Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(15)00012-5 ◽

2015 ◽

Vol 14 (5) ◽

pp. 485-496 ◽

Keyword(s):

Randomised Controlled Trial ◽

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

Controlled Trial ◽

Secondary Analysis ◽

The Third ◽

Intravenous Alteplase ◽

Randomised Controlled ◽

Imaging Signs ◽

Download Full-text

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

Trials ◽

10.1186/1745-6215-12-252 ◽

2011 ◽

Vol 12 (1) ◽

Author(s):

Peter Sandercock ◽

◽

Richard Lindley ◽

Joanna Wardlaw ◽

Martin Dennis ◽

...

Keyword(s):

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

The Third ◽

Download Full-text

Observer reliability of CT angiography in the assessment of acute ischaemic stroke: data from the Third International Stroke Trial

Neuroradiology ◽

10.1007/s00234-014-1441-0 ◽

2014 ◽

Vol 57 (1) ◽

pp. 1-9 ◽

Author(s):

Grant Mair ◽

◽

Rüdiger von Kummer ◽

Alessandro Adami ◽

Philip M. White ◽

...

Keyword(s):

Ischaemic Stroke ◽

Ct Angiography ◽

Acute Ischaemic Stroke ◽

The Third ◽

Observer Reliability ◽

Download Full-text